When alcohol and opioid addiction occur together, managing them concomitantly becomes challenging. Whereas some patients may not need medication for alcohol addiction, opioid abuse does require pharmacotherapy.
The opioid system is responsible for social pain and reward in the brain; therefore, understanding its underpinnings may help clinicians manage patients with depression and suicidal ideation.
Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.
With better understanding of the underlying mechanisms of transcranial direct current stimulation, clinicians will be better equipped to identify the optimal management of their patients with major depressive disorder.
Bipolar disorder is often comorbid with substance use disorders, with alcohol being the top substance. Clinicians should take a thorough history to uncover substance use disorder because it will guide the management of both disorders.
Before the next set of guidelines are updated and harmonized, individual studies may provide direction for clinicians.
The erythematotelangiectatic, papulopustular, phymatous, and ocular forms of rosacea can lead to psychological distress.
Patients will still be at risk for schizophrenia or bipolar disorder even several years after an episode of substance-induced psychosis.
Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.
ADHD’s many deficits cannot be ameliorated by pharmacotherapy alone. Researchers and clinicians are investigating computer interventions and physical activity that get to the root of the ADHD domain, such as inattention, memory, or time management.
